Role of microbial proteases in pathogenesis

Microbiology and Immunology

Volumn 40, Issue 10, 1996, Pages 685-699

  Maeda, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bacterial proteases; Bacterial translocation; Bradykinin; Hageman factor; Infection; Pain; Shock

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; CHEMOTACTIC FACTOR; COMPLEMENT; FIBRONECTIN; IMMUNOGLOBULIN; KININ; NEUROTOXIN; PROTEINASE; PROTEINASE INHIBITOR;

BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BLOOD CLOTTING; CYTOTOXICITY; DISSEMINATED INTRAVASCULAR CLOTTING; INFLUENZA VIRUS; MULTIPLE ORGAN FAILURE; PAIN; REVIEW; SEPTIC SHOCK; SEPTICEMIA; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); INFLUENZA VIRUS;

EID: 0029907110     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01129.x     Document Type: Review

References (81)

1. Akaike, T., Molla, A., Ando, M., Araki, S., and Maeda, H. 1989. Molecular mechanism of complex infection of bacteria and virus analyzed by a model using serratial protease and influenza virus in mice. J. Virol. 63: 2252-2259.
2. Akaike, T., Yoshida, M., Miyamoto, Y., Sato, K., Kohno, M., Sasamoto, K., Miyazaki, K., Ueda, S., and Maeda, H. 1993. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/'NO through a radical reaction. Biochemistry 32: 827-832.
3. Akaike, T., Maeda, H., Maruo, K., Sakata, Y., and Sato, K. 1994. Potentiation of infectivity and pathogenesis of influenza A virus by a house dust mite protease. J. Infect. Dis. 170: 1023-1026.
4. Blasi, F. 1988. Surface receptors for urokinase activator. Fibrinolysis 2: 73-84.
5. Blasi, J., Chapman, E.R., Link, E., Binz, T., Yamasaki, S., DeCamilli, P., Shidhof, T.C., Niemann, H., and Jahn, R. 1993. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-163.
6. Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M.H., and Sibbald, W.J. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655.
7. Bullen, J.J., and Griffiths, E. 1987. Iron and infection (A Wiley Interscience Publication), John Wiley & Sons, Chichester, New York.
8. 5a peptidase is highly specific endopeptidase. Infect. Immun. 60: 5219-5223.
9. DeKimpe, S.J., Hunter, M.L., Royant, C.E., Thiemermann, C., and Vane, J. 1995. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br. J. Pharmacol. 114: 1317-1323.
10. Feeney, R.E., and Nagy, D.A. 1952. The antibacterial activity of the egg white protein conalbumin. J. Bacteriol. 64: 629-643.
11. Ferreira, S.H., Lorenzetti, B.B., and Poole, S. 1993. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110: 1227-1231.
12. Fick, R.B., Naegel, G.P., Squire, S.U., Wood, R.E., Gee, J.B.L., and Reynolds, H.Y. 1984. Protein of the cystic fibrosis respiratory treat: fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Invest. 74: 236-258.
13. Fick, R.B., Baltimore, R.S., Squire, S.U., and Reynolds, H.Y. 1985. IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. J. Infect. Dis. 151: 589-598.
14. Ghebrehiwet, B., Randazzo, B.P., Dunn, J.T., Silverberg, M., and Kaplan, A.P. 1983. Mechanism of the activation of the classical pathway of complement by Hageman factor fragment. J. Clin. Invest. 71: 1450-1456.
15. Gonias, S.L., and Pizzo, S.V. 1983. Characterization of functional human α2-macroglobulin half-molecules isolated by limited reduction with dithiothreitol. Biochemistry 22: 536-546.
16. Gordon, V.M., and Leppla, S.H. 1994. Proteolytic activation of bacterial toxins. Role of bacterial and host cell proteases. Infect. Immun. 62: 333-340.
17. Griffin, J.A. 1996. Thrombin paradox. Nature 378: 337-338.
18. Hasui, Y., Suzumiya, F., Marutsuka, K., Sumiyoshi, A., Hashida, S., and Ishikawa, E. 1989. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. Cancer Res. 49: 1067-1070.
19. Hill, H.R., Bohnsuck, J.F., Morris, E.Z., Augustine, N.H., Parker, C.J., Clearly, P.P., and Wu, J.T. 1988. Group B Streptococci inhibits the chemotactic activity of the fifth component of complement. J. Immunol. 141: 3551-3556.
20. Ijiri, Y., Kamata, R., Nishino, N., Okamura, R., Kambara, T., and Yamamoto, T. 1994. Suppression of polymorphonuclear lenkocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: a study of the mechanism and the correlation with ring abscess in Pseudomonas keratitis. Int. J. Exp. Pathol. 75: 441-451.
21. Imamura, T., Pike, R.N., Potempa, J., and Travis, J. 1994. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 94: 361-367.
22. Imamura, T., Potempa, J., Pike, R.N., and Travis, J. 1995. Dependent of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect. Immun, 63: 1999-2003.
23. Kamata, R., Matsumoto, K., Okamura, R., Yamamoto, T., and Maeda, H. 1985. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Ophthalmology 92: 1452-1459.
24. Kamata, R., Yamamoto, T., Matsumoto, K., and Maeda, H. 1985. A serratial protease causes vascular permeability reaction by activation of the Hageman factor dependent pathway in guinea pigs. Infect. Immun. 48: 747-753.
25. Kaminishi, H., Tanaka, M., Cho, T., Maeda, H., and Hagihara, Y. 1990. Activation of the plasma kallikrein-kinin system by Candida albicans protease. Infect. Immun. 58: 2139-2143.
26. Kaminishi, H., Cho, T., Itoh, T., Iwata, A., Kawasaki, K., Hagihara, Y., and Maeda, H. 1993. Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs. FEMS Microbiol. Lett. 114: 109-114.
27. Kaminishi, H., Miyaguchi, H., Tamaki, T., Suenaga, N., Hisamitsu, M., Mihashi, I., Matsumoto, H., Maeda, H., and Hagihara, Y 1995. Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun. 63: 984-988.
28. Katori, M., Majima, M., Odoi-Adome, R., Sunahara, N., and Uchida, Y. 1989. Evidence for the involvement of a kallikrein-kinin system in the immediate hypotension produced by endotoxin. Br. J. Pharmacol. 98: 1381-1391.
29. Khan, M.M.H., Shibuya, Y., Nakagaki, T., Kambara, T., and Yamamoto, T. 1994. Alpha-2-macroglobulin as the major defense in acute pseudomonal septic shock in the guinea-pig model. Int. J. Exp. Pathol. 75: 285-293.
30. Khan, M.M.H., Shibuya, Y., Kambara, T., and Yamamoto, T. 1995. Role of alpha-2-macroglobulin and bacterial elastase in guinea-pig pseudomonal septic shock. Int. J. Exp. Pathol. 76: 21-28.
31. Lottenberg, R., Minning-Wenz, D., and Boyle, M.D.P. 1994. Capturing host plasmin(ogen): a common mechanism for invasive pathogen. Trends Microbiol. 2: 20-24.
32. 2-macroglobulin and regeneration of protease activity and cytotoxicity. J. Biol. Chem. 262: 10946-10950.
33. Maeda, H., and Molla, A. 1989. Pathogenic potentials of bacterial proteases. Clin. Chem. Acta 185: 357-368.
34. Maeda, H., Matsumura, Y., and Molla, A. 1987. Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection. Cancer Res. 47: 563-566.
35. 2-macroglobulin receptor. Cancer Res. 49: 660-664.
36. Maeda, H., Akaike, T., Sakata, Y., and Maruo, K. 1993. Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin, p. 159-165. In Cheronis, J.C., and Repine, I.E. (eds), Agents and actions, Supplements 42, Protease, protease inhibitor and proteasederived peptides: importance in human pathophysiology and therapeutics, Birkhäuser Verlag AG, Switzerland.
37. Maeda, H., and Morihara, K. 1995. Serralysin and related bacterial proteases, p.395-413. In Barrett, A.J. (ed), Methods in enzymology, Vol. 248, Proteolytic enzymes: aspartic and metallo peptidases, Academic Press, Inc., New York.
38. Maeda, H., Shin, Y-H., Akaike, T., and Yoshida, M. 1996. Septic shock: prevention by NO-scavenger (PTIO) and by kinin inhibitor. Shock (in press).
39. Maeda, H., Akaike, T., Wu, J., Noguchi, Y., and Sakata, Y. 1996. Bradykinin and nitric oxide in infectious disease and cancer. J. Immunopharmacol. 33: 222-230.
40. Maeda, H., and Yamamoto, T. 1996. Pathogenic mechanisms induced by microbial proteases in microbial infection. Biol. Chem. Hoppe-Seyler 377: 217-226.
41. Maruo, K., Akaike, T., Matsushima, Y., Kohmoto, S., Inada, Y., Ono, T., Arao, T., and Maeda, H. 1991. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase. Biochim. Biophys. Acta 1074: 62-68.
42. Maruo, K., Maeda, H., Akaike, T., Inada, Y., Ohkubo, I., and Ono, T. 1993. Effect of microbial and mite proteases on low- and high-molecular-weight kininogens: generation of kinin and inactivation of thiol-protease inhibitory activity. J. Biol. Chem. 268: 17711-17715.
43. Matsumoto, K., Yamamoto, T., Kamata, R., and Maeda, H. 1984. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. J. Biochem. 96: 739-749.
44. Matsumoto, K., Shams, N.B. K., Honninen, L.A., and Kenyon, K.R. 1993. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Invest. Ophthalmol. Visual Sci. 34: 1945-1953.
45. Miyagawa, S., Kamata, R., Matsumoto, K., Okamura, R., and Maeda, H. 1991. Inhibitory effects of ovomacroglobulin on bacterial keratitis in rabbits. Graefe's Arch. Clin. Exp. Ophthalmol. 229: 281-286.
46. Miyagawa, S., Matsumoto, K., Kamata, R., Okamura, R., and Maeda, H. 1991. Serratia marcescens in experimental keratitis and growth suppression by chicken egg white ovomacroglobulin. Jpn. J. Ophthalmol. 25: 402-410.
47. Miyagawa, S., Nishino, N., Okamura, R., and Maeda, H. 1991. Effects of protease inhibitors on growth of Serratia marcescens and Pseudomonas aeruginosa: chicken egg white ovomacroglobulin is a potent growth suppressor. Microb. Pathog. 11: 137-141.
48. Miyagawa, S., Kamata, R., Matsumoto, K., Okamura, R., and Maeda, H. 1994. Therapeutic intervention with chicken egg white ovomacroglobulin and a new quinolone on experimental Pseudomonas keratitis. Graefe's Arch. Clin. Exp. Ophthalmol. 232: 488-493.
49. Molla, A., Matsumoto, K., Oyamada, L, Katsuki, T., and Maeda, H. 1986. Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblasts in culture. Infect. Immun. 53: 522-529.
50. 2-macroglobulin and chicken egg white ovomacroglobulin. J. Biochem. 101: 199-205.
51. Molla, A., Kagimoto, T., and Maeda, H. 1988. Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens. Infect. Immun. 56: 916-920.
52. Molla, A., Tanase, S., Hong, Y., and Maeda, H. 1988. Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens. Biochim. Biophys. Acta 955: 77-85.
53. Molla, A., Akaike, T., and Maeda, H. 1989. Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens. Infect. Immun. 57: 1868-1871.
54. Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S. and Maeda, H. 1989. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J. Biol. Chem. 264: 10589-10594.
55. Montecucco, C., and Schiavo, G. 1993. Tetanus and botulinum neurotoxins: a new group of zinc proteases. TIBS 18: 324-327.
56. 1 proteinase inhibitor. Infect. Immun. 24: 188-193.
57. Mulks, M.H. 1983. Microbial IgA proteases, p. 82-101. In Holder, I.A. (ed), Bacterial enzymes and virulence, CRC Press, Boca Raton, Florida.
58. Murakami, A., Sakamoto, K., Kojima, Y., Sasaki, Y., and Maeda, H. 1992. Antitumor effect of bacterial proteases on various human cancer xenografts in nude mice. Regional Cancer Treatment 4: 200-206.
59. 5a by serratial 56-kilodalton protease. Infect. Immun. 58: 1269-1272.
60. Okujo, N., Akiyama, T., Miyoshi, S., Sinoda, S., and Yamamoto, S. 1996. Involvement of vulnibactin and extracellular protease in utilization of transferrin- and lactotransferrin-bound iron by Vibrio vulnificus. Microbiol. Immunol. 40: 595-598.
61. Palmer, R.M.J., Ferrige, A.G., and Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327: 524-526.
62. 1 proteases of pathogenic bacteria. Annu. Rev. Microbiol. 37: 603-622.
63. 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261: 14330-14334.
64. Potempa, J., Pavlott, N., and Travis, J. 1995. Porphyromonas gingivalis: a proteinase/gene accounting audit. Trend Microbiol. 3: 430-434.
65. Proud, D., Nuclerio, R.M., Gwaltney, J.M., and Hendley, J.O. 1990. Kinins are generated in nasal secretions during natural rhinovirus cold. J. Infect. Dis. 161: 120-123.
66. Sakata, Y., Akaike, T., Suga, M., Ijiri, S., Ando, M., and Maeda, H. 1996. Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol. Immunol. 40: 415-423.
67. Schiavo, G., Benfenati, F., Poulain, Rossetto, O., de Laureto, P.P., Das Gupta, B.R., and Montecucco, C. 1992. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359: 832-835.
68. Shimada, T., Kato, H., Maeda, H., and Iwanaga, S. 1985. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide; Analysis by fluorescence polarization. J. Biochem. 97: 1637-1644.
69. 1/2. J. Immunopharmacol. 33: 369-373.
70. 9-bradykinin increases during E. coli septicemia in the pig, p. 389-393. In Abe, K., Moriya, H., and Fujii, S. (eds), Kinin V., Plenum Pub. Co.
71. Siebeck, M., Fink, E., Weipert, J., Jochum, M., Fritz, H., Spannagi, M., Kroworsch, P., Shimamoto, K., and Scheiberer, L.S. 1993. Inhibition of plasma kallikrein with approtinin in porcine endotoxin. J. Trauma 34: 193-198.
72. 2 kinin receptors. J. Appl. Physiol. 77: 2675-2680.
73. Sorsa, T., Ingman, T., Suomalainen, K., Haapasalo, M., Konttinen, Y., Lindy, O., Saari, H., and Uitto, V.-J. 1992. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblasttype interstitial collagenases. Infect. Immun. 60: 4491-4495.
74. Ueno, A., Ishida, H., and Oh-ishi, S. 1995. Comparative study of endotoxin induced hypotension in kininogen deficient rats with that of normal rats. Br. J. Pharmacol. 114: 1250-1256.
75. Uitto, V.-J., Larjava, H., Heino, J., and Sorsa, T. 1989. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect. Immun. 57: 213-218.
76. Vandekerckhove, F., Opdenakker, G., Van Ranst, M., Lenaerts, J.-P., Put, W., Billiau, A., and Van Damme, J. 1991. Bradykinin induces interleukin-6 and synergizes with interleukin-1. Lymph. Cytokine Res. 10: 285-289.
77. Vane, J.R. 1994. Towards a better aspirin. Nature 367: 215-216.
78. Weinberg, E.D. 1993. The iron-withholding defense system. ASM News 56: 559-562.
79. 7]-Bk (B4148). Br. J. Pharmacol. 94: 282-284.
80. Wooldridge, K.G., and Williams, P.H. 1993. Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol. Lett. 12: 325-348.
81. Yoshida, M., Akaike, T., Wada, Y., Sato, K., Ikeda, K., Ueda, S., and Maeda, H. 1994. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem. Biophys. Res. Commun. 202: 923-930.